ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.115
      -0.45%
      Bitcoin
      55,148.16
      -1.25%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Celgene Corporation (CELG)

      7. Celgene Corporation (CELG) News

      CELG

      Celgene (CELG)

      Celgene Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CELG
      DateTimeSourceHeadlineSymbolCompany
      03/21/20189:30AMPR Newswire (US)S&P 500 Q4 2017 Buybacks Rose 6.0% to $137.0 Billion; Full-Year 2017 Fell 3.2% to $519.4 BillionNASDAQ:CELGCelgene Corporation
      03/20/20184:05PMGlobeNewswire Inc.Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients wit...NASDAQ:CELGCelgene Corporation
      03/13/20184:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      03/06/20185:02PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CELGCelgene Corporation
      03/06/20188:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELGCelgene Corporation
      03/06/20187:30AMBusiness WireCelgene Completes Acquisition of Juno Therapeutics, Inc., Advancing Global Leadership in Cellular ImmunotherapyNASDAQ:CELGCelgene Corporation
      03/05/20187:30AMBusiness WireCelgene Announces Expiration of Cash Tender Offer for Shares of Juno Therapeutics, Inc.NASDAQ:CELGCelgene Corporation
      03/01/20185:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      03/01/20182:45AMBusiness WireRésultats positifs pour la phase III d’OTEZLA® (aprémilast) chez les patients atteints de maladie de BehçetNASDAQ:CELGCelgene Corporation
      03/01/20182:30AMBusiness WireRésultats de phase II positifs concernant OTEZLA® (aprémilast) chez les patients atteints de rectocolite hémorragique ac...NASDAQ:CELGCelgene Corporation
      02/27/20185:41PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELGCelgene Corporation
      02/27/20184:30PMBusiness WireCelgene Provides Regulatory Update on Ozanimod for the Treatment of Relapsing Multiple SclerosisNASDAQ:CELGCelgene Corporation
      02/27/20187:30AMBusiness WireCelgene Corporation to Webcast at Upcoming Investor ConferencesNASDAQ:CELGCelgene Corporation
      02/26/20184:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      02/23/20182:45AMBusiness WirePhase-III-Daten zu Apremilast (OTEZLA®) zeigen signifikante Verbesserungen bei Patienten mit aktivem Morbus Behçet und oral...NASDAQ:CELGCelgene Corporation
      02/23/20182:30AMBusiness WirePhase-II-Daten zu Apremilast (OTEZLA®) zeigten klinisch bedeutsame Verbesserungen bei Patienten mit aktiver Colitis ulcerosaNASDAQ:CELGCelgene Corporation
      02/21/20187:30AMBusiness WireCelgene Receives Antitrust Clearance for Juno AcquisitionNASDAQ:CELGCelgene Corporation
      02/20/20185:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      02/20/20185:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      02/20/20185:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      02/20/20185:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      02/20/20184:55PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CELGCelgene Corporation
      02/19/20189:17AMBusiness WireMALATTIA DI BEHÇET, CONFERME DI EFFICACIA PER APREMILAST IN FASE III NEI PAZIENTI CON ULCERE ORALI IN FASE ATTIVANASDAQ:CELGCelgene Corporation
      02/19/20182:00AMBusiness WireAPREMILAST, CONFERME DI EFFICACIA IN FASE II NEI PAZIENTI CON COLITE ULCEROSA ATTIVANASDAQ:CELGCelgene Corporation
      02/17/20184:00PMBusiness WireOTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ul...NASDAQ:CELGCelgene Corporation
      02/15/20184:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      02/15/20184:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      02/15/20184:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      02/15/20184:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CELGCelgene Corporation
      02/15/20184:08PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CELGCelgene Corporation
       Showing the most relevant articles for your search:NASDAQ:CELG

      Your Recent History

      BOV
      WHRL3Q
      WHIRLPOOL ON
      Delayed Upgrade Clock